Anixa Biosciences, Inc.ANIXNASDAQ
Loading
Year-over-year research & development expense growth
Percentile
P29
Within normal range
vs 3Y Ago
-2.5x
Contraction
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | -20.72% |
| 2024 | 34.12% |
| 2023 | -28.85% |
| 2022 | 8.29% |
| 2021 | 41.28% |
| 2020 | -19.95% |
| 2019 | -19.66% |
| 2018 | 326.47% |
| 2017 | 2.64% |
| 2016 | 118.79% |